Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
暂无分享,去创建一个
Abidemi K. Adeniji | P. Vermersch | G. Comi | G. Giovannoni | P. Rieckmann | S. Cook | P. Soelberg Sørensen | F. Dangond | K. Rammohan